StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 3.3
Power Rank trend -> Rising
07/26/2024 16:15:00 EST
Bruker Corporation (BRKR)
Industry: Medical Devices
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, BRKR has been trading in a range between $66.25 and $61.21 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
BRKR is trading between resistance at $68.80 about 3% to the upside and support at $61.21 -8% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $73.52, about a 10% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
Bruker Corporation $BRKR entered a Green zone 1 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $77.78, a potential upside of 16.42% from the recent price of 66.81. The stock is trading 41.88% (potential upside) below its 52 week high of $94.79 and 24.46 % (potential downside) above its 52 week low of $53.68 - based on the recent price.
Company Summary
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.
News
| Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Source: Zacks Investment Research Thu, 25 Jul 2024 11:07:53 -0400 Sentiment: Neutral |
| Bruker Announces that Injunction Impacting NanoString's CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that it has posted a bond, as authorized by the Munich Higher Regional Court, in order to suspend an injunction that had been impacting sales of CosMx™ Spatial Molecular Imager (SMI) products by its NanoString business in Germany. This development is connected with ongoing patent litigation with 10x Genomics, during an appeal process in Germany. Effective immediately, all CosMx products are once again available. Source: Business Wire Thu, 18 Jul 2024 07:00:00 -0400 Sentiment: Neutral |
| 7 Quantum Computing Stocks That Could Be Multibaggers in the Making: July Edition Quantum computing is still relatively new which means that there is a lot of opportunity when it comes to quantum computing stocks. Advancements in quantum computing technology such as the superconducting qubits and the trapped ion technology have boosted the efficiency and effectiveness of quantum systems. Source: InvestorPlace Wed, 17 Jul 2024 07:25:00 -0400 Sentiment: Positive |
| Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report? Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Source: Zacks Investment Research Wed, 10 Jul 2024 13:11:18 -0400 Sentiment: Positive |
| Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds Bruker's (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand. Source: Zacks Investment Research Tue, 09 Jul 2024 11:20:33 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 94.7875 52 Week Low: 53.6767 Beta: 1.197 50 Day MA: 66.709 200 Day MA: 72.5417 Earnings / Revenue Trends Qtr Earnings Growth YOY: -0.327 Qtr Revenue Growth YOY: 0.053 Forward PE: 31.9489 Trailing PE: 23.5275